Lyric Pharmaceuticals Inc. — Form D/A
Lyric Pharmaceuticals Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2017-04-24. The offering totals $33.9M, of which $26.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-04-24
- Form: D/A
- Accession: 0001634389-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $33.9M
- Amount sold: $26.8M
- Remaining: $7.1M
- Investors: 13
- Date of first sale: 2015-02-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-234847
Issuer
- Name: Lyric Pharmaceuticals Inc.
- CIK: 0001634389
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 601 GATEWAY BLVD., SUITE 1020, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (650) 866-8070
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Casey Cunningham | Director | Milwaukee, WI |
| JASON HONG | Director | STAMFORD, CT |
| Niall O'Donnell | Director | St. Louis, MO |
| David Wurtman | Director | South San Francisco, CA |
| Sanford Zweifach | Director | South San Francisco, CA |
| M. Scott Harris | Executive Officer | South San Francisco, CA |
| David Wurtman | Executive Officer | South San Francisco, CA |
| Kevin Lalande | Director | Medford, MA |
Other filings by this issuer (1)
More